Scientists reported that atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide accelerated the dopaminergic differentiation of human induced pluripotent stem cells (hiPSCs)-derived neural population, making these attractive molecules for both neuroprotection and neurorepair in Parkinson’s disease (PD).
[Cell Death Discovery]
7992332
{7992332:45XWATNZ}
apa
50
1
168566
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/